Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Steroid induced glaucoma].

Ruth Sapir-Pichhadze1, Eytan Z Blumenthal

  • 1Department of Opthalmology, Hadassah University Hospital, Jerusalem, Israel.

Harefuah
|March 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic Dysfunction-Associated Steatotic Liver Disease and Kidney Transplant Outcomes.

Kidney international reports·2026
Same author

Artificial intelligence in retinal care: transforming the doctor-patient partnership.

International journal of retina and vitreous·2026
Same author

The Banff 2024 Kidney Meeting Report: Rejection as a spectrum of phenotypes and focus on differential diagnostic reasoning.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

HLA Experts' Perspectives on Precision Medicine and Molecular Matching in Kidney Transplantation: A Qualitative Study.

Canadian journal of kidney health and disease·2026
Same author

A multinational qualitative study examined the perspectives and experiences of women with a kidney transplant on access to healthcare.

Kidney international·2025
Same author

GONet: A Generalizable Deep Learning Model for Glaucoma Detection.

IEEE transactions on bio-medical engineering·2025
Same journal

[Tennis Elbow Among Players].

Harefuah·2026
Same journal

[Internal Medicine - My Mission].

Harefuah·2026
Same journal

[Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

Harefuah·2026
Same journal

[Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

Harefuah·2026
Same journal

[Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

Harefuah·2026
Same journal

[Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

Harefuah·2026
See all related articles

Steroid medications can cause ocular hypertension and open-angle glaucoma, especially in "steroid responders." Regular eye exams are crucial for monitoring intraocular pressure during steroid treatment.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Genetics

Context:

  • Steroid therapy, while beneficial, is associated with significant ocular side effects.
  • Ocular hypertension and secondary open-angle glaucoma are known risks of corticosteroid use.
  • Approximately one-third of individuals are considered 'steroid responders,' exhibiting elevated intraocular pressure.

Purpose:

  • To review the mechanisms and implications of steroid-induced ocular hypertension and glaucoma.
  • To highlight the role of genetic factors, such as the TIGR/GLCIA gene, in steroid responsiveness.
  • To emphasize the importance of regular ophthalmologic monitoring for patients on steroid treatment.

Summary:

  • Steroid administration (local, regional, inhalation, or systemic) can lead to ocular hypertension and potentially open-angle glaucoma.

Related Experiment Videos

  • Individuals with a family history of open-angle glaucoma are at higher risk.
  • The proposed mechanism involves steroid-induced changes in the trabecular meshwork, possibly via the TIGR/GLCIA gene product, myocilin.
  • Impact:

    • Steroid-induced ocular hypertension is often reversible if treatment duration is less than 12 months.
    • The asymptomatic nature of ocular hypertension necessitates regular eye examinations, including tonometry, visual fields, and optic disc assessment.
    • Early detection and monitoring are vital to prevent irreversible vision loss from steroid-induced glaucoma.